Multiple sclerosis. Demyelinating diseases of the central nervous system
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion Criteria: Multiple Sclerosis patients with ability to walk 10 meter in a less than 1 minute (with or without aim) exclusion Criteria: Sever decrease of functional ability during last year; Pregnancy; Corticosteroid treatment during last month, Sever Psychological condition, Any conditions cause to prevent mild or moderate sport activities; regular sport activity twice a week for more than 10 minutes in each session; simultaneously present another medical condition such as diabetic; lower limb arthritis; unstable cardiovascular conditions that cause noncooperation of subject during intervention
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Two-Minute Walk. Timepoint: Before and after intervention and also after 4 weeks follow-up. Method of measurement: By meter.;Timed 25 Foot Walk. Timepoint: Before and after intervention and also after 4 weeks follow-up. Method of measurement: By chronometer.;Timed Get-up and Go. Timepoint: Before and after intervention and also after 4 weeks follow-up. Method of measurement: By Chronometer.;Static Balance Index. Timepoint: Before and after intervention and also after 4 weeks follow-up. Method of measurement: By Biodex Balance System.;Dynamic Balance Index. Timepoint: Before and after intervention and also after 4 weeks follow-up. Method of measurement: By Biodex Balance System.;Maximum isometric torque of quadriceps muscles. Timepoint: Before and after intervention and also after 4 weeks follow-up. Method of measurement: By Biodex Isokinetic Device 4Pro.;Maximum isometric torque of hamstring muscles. Timepoint: Before and after intervention and also after 4 weeks follow-up. Method of measurement: By Biodex Isokinetic Device 4Pro. | — |
Secondary
| Measure | Time frame |
|---|---|
| Disability Rate. Timepoint: Before and after intervention and also after 4 weeks follow-up. Method of measurement: Guy’s Neurological Disability Scale.;Ability rate. Timepoint: Before and after intervention and aslo after 4 weeks follow-up. Method of measurement: Rivermead Mobility Index (RMI). | — |
Countries
Iran (Islamic Republic of)
Contacts
Semnan University of Medical Sciences